Gabriel Corfas

Summary

Affiliation: Harvard University
Country: USA

Publications

  1. ncbi Neuregulin 1-erbB signaling and the molecular/cellular basis of schizophrenia
    Gabriel Corfas
    Division of Neuroscience, Children s Hospital, and Department of Neurology, Harvard Medical School, Boston, Massachusetts 02115, USA
    Nat Neurosci 7:575-80. 2004
  2. ncbi Targeting angiogenesis with a conjugate of HPMA copolymer and TNP-470
    Ronit Satchi-Fainaro
    Vascular Biology Program and Department of Surgery, Boston Children's Hospital and Harvard Medical School, 1 Blackfan Circle, New Research Building, Boston, Massachusetts 02115, USA
    Nat Med 10:255-61. 2004
  3. ncbi An orally delivered small-molecule formulation with antiangiogenic and anticancer activity
    Ofra Benny
    Vascular Biology Program and Department of Surgery, Children s Hospital Boston, Harvard Medical School, 1 Blackfan Circle, St Karp Research Building, Boston, Massachusetts 02215, USA
    Nat Biotechnol 26:799-807. 2008
  4. ncbi Disruption of ErbB receptor signaling in adult non-myelinating Schwann cells causes progressive sensory loss
    Suzhen Chen
    Division of Neuroscience, Children s Hospital, Harvard Medical School, 300 Longwood Avenue, Boston, Massachusetts 02115, USA
    Nat Neurosci 6:1186-93. 2003
  5. ncbi Mechanisms and roles of axon-Schwann cell interactions
    Gabriel Corfas
    Division of Neuroscience, Children's Hospital, Boston, Massachusetts 02115, USA
    J Neurosci 24:9250-60. 2004
  6. ncbi Neuregulin 1-erbB signaling is necessary for normal myelination and sensory function
    Suzhen Chen
    Division of Neuroscience, Children s Hospital Boston, Harvard Medical School, Boston, Massachusetts 02115, USA
    J Neurosci 26:3079-86. 2006
  7. ncbi Presenilin-dependent ErbB4 nuclear signaling regulates the timing of astrogenesis in the developing brain
    S Pablo Sardi
    Neurobiology Program and Department of Neurology, Children s Hospital and Harvard Medical School, 300 Longwood Avenue, Boston, MA, 02115, USA
    Cell 127:185-97. 2006
  8. ncbi Neuregulin1 downregulates postsynaptic GABAA receptors at the hippocampal inhibitory synapse
    Masayoshi Okada
    Department of Neurophysiology, University of Tokyo Graduate School of Medicine, Tokyo, Japan
    Hippocampus 14:337-44. 2004

Collaborators

  • Judah Folkman
  • Hai T Tran
  • Ofer Fainaru
  • Ofra Benny
  • Joseph Buxbaum
  • Suzhen Chen
  • S Pablo Sardi
  • Ronit Satchi-Fainaro
  • Masayoshi Okada
  • Brooke A Patten
  • Joshua Murtie
  • Shyra J Miller
  • Xavier Warot
  • Zhao Xue Yu
  • Miguel Omar Velardez
  • Samir Koirala
  • Didier Cros
  • Zhao-Xue Yu
  • Arin K Greene
  • John W Davies
  • David A Sampson
  • Mark Puder
  • Ru Rong Ji
  • Clifford J Woolf
  • Richard E Coggeshall
  • Carlos Rio
  • Ru-Rong Ji
  • Pieter Dikkes

Detail Information

Publications8

  1. ncbi Neuregulin 1-erbB signaling and the molecular/cellular basis of schizophrenia
    Gabriel Corfas
    Division of Neuroscience, Children s Hospital, and Department of Neurology, Harvard Medical School, Boston, Massachusetts 02115, USA
    Nat Neurosci 7:575-80. 2004
    ..These findings open new approaches to defining the molecular and cellular basis of schizophrenia in more mechanistic terms...
  2. ncbi Targeting angiogenesis with a conjugate of HPMA copolymer and TNP-470
    Ronit Satchi-Fainaro
    Vascular Biology Program and Department of Surgery, Boston Children's Hospital and Harvard Medical School, 1 Blackfan Circle, New Research Building, Boston, Massachusetts 02115, USA
    Nat Med 10:255-61. 2004
    ..This new approach for targeting angiogenesis inhibitors specifically to the tumor vasculature may provide a new strategy for the rational design of cancer therapies...
  3. ncbi An orally delivered small-molecule formulation with antiangiogenic and anticancer activity
    Ofra Benny
    Vascular Biology Program and Department of Surgery, Children s Hospital Boston, Harvard Medical School, 1 Blackfan Circle, St Karp Research Building, Boston, Massachusetts 02215, USA
    Nat Biotechnol 26:799-807. 2008
    ..We show that Lodamin is an oral nontoxic antiangiogenic drug that can be chronically administered for cancer therapy or metastasis prevention...
  4. ncbi Disruption of ErbB receptor signaling in adult non-myelinating Schwann cells causes progressive sensory loss
    Suzhen Chen
    Division of Neuroscience, Children s Hospital, Harvard Medical School, 300 Longwood Avenue, Boston, Massachusetts 02115, USA
    Nat Neurosci 6:1186-93. 2003
    ....
  5. ncbi Mechanisms and roles of axon-Schwann cell interactions
    Gabriel Corfas
    Division of Neuroscience, Children's Hospital, Boston, Massachusetts 02115, USA
    J Neurosci 24:9250-60. 2004
  6. ncbi Neuregulin 1-erbB signaling is necessary for normal myelination and sensory function
    Suzhen Chen
    Division of Neuroscience, Children s Hospital Boston, Harvard Medical School, Boston, Massachusetts 02115, USA
    J Neurosci 26:3079-86. 2006
    ..These results suggest that disruption of the NRG1-erbB signaling pathway could contribute to the pathogenesis of peripheral neuropathies with hypomyelination and neuropathic pain...
  7. ncbi Presenilin-dependent ErbB4 nuclear signaling regulates the timing of astrogenesis in the developing brain
    S Pablo Sardi
    Neurobiology Program and Department of Neurology, Children s Hospital and Harvard Medical School, 300 Longwood Avenue, Boston, MA, 02115, USA
    Cell 127:185-97. 2006
    ..This pathway could be of importance for neural stem cell biology and for understanding the pathogenesis of Alzheimer's disease...
  8. ncbi Neuregulin1 downregulates postsynaptic GABAA receptors at the hippocampal inhibitory synapse
    Masayoshi Okada
    Department of Neurophysiology, University of Tokyo Graduate School of Medicine, Tokyo, Japan
    Hippocampus 14:337-44. 2004
    ....